May 06, 2020
Rose
Two new graphics from Diabetes UK's COVID-19 task force address inpatient use of subcutaneous insulin for managing hyperglycemia and ketoacidosis when intravenous equipment is unavailable.
from WebMD Health https://ift.tt/3deJTZw
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment